Patients can typically return to their normal activities immediately after the injection.
The information presented here is based on current research, which is ongoing and evolving
Regular moderate exercise reduces systemic inflammation and improves immune regulation
For most adults with newly diagnosed type 2 diabetes without cardiorenal disease, metformin plus lifestyle modification remains initial therapy, with GLP-1 agonists as preferred second-line agents
Questions remain about substance characterization, dosing, long-term safety information, human research, and the difference between anecdotal use and evidence gathered through larger studies
As a glucagon-like peptide-1 (GLP-1) receptor agonist, Semaglutide GLP-1 is the generic name of a medication primarily used to help manage blood sugar levels in adults with type 2 diabetes